Primary endpoint of safety and tolerability met successfully Positive impact on exploratory clinical efficacy parameters: REVEAL risk score: 43% (9/21) of
At the Capital Markets Day 2023, Sandvik communicated the intention to increase the focus on software solutions and enabling hardware